A pre-filled syringe filled with a white liquid and a vial filled with a lyophilized powder, forming a white suspension upon reconstitution

Diphtheria Toxoid (Strain: 1514-N-3S) ≥30 IU, Tetanus Toxoid (Strain: 1472-C) ≥40 IU, Pertussis Toxoid (Strain: 1591) 25 μg, Filamentous Hemagglutinin (FHA) (Strain: 1591) 25 μg, Inactivated Poliovirus Type I (Strain: Mahoney) 40 DU, Inactivated Poliovirus Type II (Strain: MEF-1) 8 DU, Inactivated Poliovirus Type III (Strain: Saukett) 32 DU in one pre-filled syringe

Polysaccharide of H. influenzae type b Conjugated to Tetanus Protein 10 μg in one vial

Prevention of diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease caused by Haemophilus influenzae type b

Primary Immunization: Administer 3 doses of 0.5 mL each at 2, 4, and 6 months of age.

Reconstitute the lyophilized powder vial with the suspension in the pre-filled syringe and administer intramuscularly. For infants, inject into the anterolateral aspect of the upper thigh.

1 pack (1 single-dose vial of lyophilized Hib + 1 single-dose pre-filled syringe of 0.5 mL DTaP-IPV)

2 sterile needles

Store in a tightly closed container at 2~8℃. Avoid freezing.